Ampio Pharmaceuticals Inc (AMPE)
NYSE
0.1831
0.00 (0.00%)
Real-time Data
01:30 PM
Day's Range
0.18310.1831
52 wk Range
0.002700.6435
Financial Statements - AMPE - Ampio Pharmaceuticals Inc
Revenue
0
Net Income
-8.63M▲ 47.2%
EBITDA
-9.34M▲ 59.7%
Free Cash Flow
-8.56M▲ 59.5%
Income Statement
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - |
| Gross Profit | - | - | - | - |
 Operating Expense | - | - | - | - |
| Operating Income | -9.51M | -20.38M | -20.57M | -15.83M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | 538K | 3.82M | 3.49M | -72K |
| Pre Tax Income | -8.63M | -16.33M | -17.07M | -15.89M |
| Income Tax | - | - | - | - |
| Net Income | -8.63M | -16.33M | -17.07M | -15.89M |
| EPS Basic | - | -21.68 | -27 | -27 |
| EPS Diluted | - | -29.32 | -30 | -27 |
| Basic Shares Outstanding | - | 753.61K | 664.33K | 576.15K |
| Diluted Shares Outstanding | - | 753.61K | 664.33K | 576.15K |
| Ebit | -9.51M | -20.38M | -20.57M | -15.83M |
| Ebitda | -9.34M | -23.15M | -22.96M | -14.58M |
| Net Income Continuous Operations | -8.63M | -16.33M | -17.07M | -15.89M |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
